申请人:UBE Industries, Ltd.
公开号:EP2940013A1
公开(公告)日:2015-11-04
A novel α-halogen-substituted thiophene compound or a pharmacologically acceptable salt thereof, which has a potent LPA receptor-antagonist activity and is useful as a medicament is provided.
A compound represented by the general formula (I) wherein A represents, a phenyl ring, a thiophene ring, or an isothiazole ring; R1 is the same or different, and represents a halogen atom, or a C1-C3 alkyl group; R2 represents a hydrogen atom, or a C1-C6 alkyl group; p represents an integer of 0 to 5; V represents CR3 wherein R3 represents a hydrogen atom, an amino group, a nitro group, or a C1-C3 alkoxy group, or V represents a nitrogen atom; and X represents a halogen atom, or a salt thereof.
本发明提供了一种新型α-卤素取代的噻吩化合物或其药理学上可接受的盐,该化合物具有强效的LPA受体拮抗剂活性,可用作药物。
通式(I)代表的化合物 其中A代表苯基环、噻吩环或异噻唑环;R1相同或不同,代表卤素原子或C1-C3烷基;R2代表氢原子或C1-C6烷基;p代表0~5的整数;V代表CR3,其中R3代表氢原子、氨基、硝基或C1-C3烷氧基,或V代表氮原子;X代表卤素原子或其盐。